Research Article

Ocular Findings Before and After Pegylated Interferon Treatment in Chronic Hepatitis B and C Patients
  • Şükran KÖSE
  • Melda TÜRKEN
  • Lütfiye KUZUCU
  • Gamze TÜRE
  • Tümay ÖRSEL
Viral Hepat J 2014; 20: 1-3 DOI: 10.4274/Vhd.35229
A Comparison of Interferon α-2a Plus Ribavirin Combination Therapy with Peginterferon α-2a Plus Ribavirin Combination Therapy for the Treatment of Chronic Hepatitis C
  • Hayati DEMİRASLAN
  • Bilgehan AYGEN
  • Orhan YILDIZ
  • Işın SOYUER
  • Selma GÖKAHMETOĞLU
Viral Hepat J 2008; 13: 12-22
The Role of the Basal Core Promoter (BCP) and Precore Codon 28 Mutations in the Treatment Response to the Pegylated Interferon
  • Şükran KÖSE
  • Süheyla Serin SENGER
  • Gülsün ÇAVDAR
  • Pelin ADAR
Viral Hepat J 2014; 20: 19-22 DOI: 10.4274/Vhd.74946
The Evaluation of the Side Effects of Pegilated Interferon Monotherapy and Pegilated Interferon /Lamivudin Treatment in Patients With Chronic Hepatitis B
  • Kutbettin DEMİRDAĞ
  • Gülden ESER KARLIDAĞ
Viral Hepat J 2009; 14: 47-52
Relationship between HBV-DNA Level and Treatment Success in HBeAg Negative Patients Treated with Pegylated Interferone
  • Ertuğrul GÜÇLÜ
  • Nazan TUNA
  • Mehmet YAHYAOĞLU
  • Oğuz KARABAY
Viral Hepat J 2012; 18: 60-63 DOI: 10.4274/Vhd.22932
The Effectivity of Combination of Standard Interferon-a + Ribavirin and Pegylated Interferon-a + Ribavirin Therapy in Patients with Chronic Hepatitis C
  • Nail ÖZGÜNES
  • Fatma SARGIN
  • Saadet YAZICI
  • Nüket CEYLAN
  • Ayse Canan ÜÇISIK
  • Pinar ERGEN
  • Arzu DOGRU
  • Özlem AYDIN
Viral Hepat J 2006; 11: 61-64
The Evaluation of Pegylated Interferon Therapy in Patients with Chronic Hepatitis Delta
  • Ayşe ALBAYRAK
  • Muharrem COŞKUN
  • Ahmet UYANIKOĞLU
  • Yasin BAYIR
  • Havva YILMAZ
  • Yunus İlyas KİBAR
  • Ahmet TAY
  • Fatih ALBAYRAK
Viral Hepat J 2012; 18: 68-70 DOI: 10.4274/Vhd.32032
Evaluation of 219 Patients with Chronic Hepatitis C Receiving Pegylated Interferon + Ribavirin Treatment
  • Nevil AYKIN
  • Figen ÇAĞLAN ÇEVİK
  • Hasan NAZ
  • Pınar KORKMAZ
  • Tercan US
Viral Hepat J 2013; 19: 71-75 DOI: 10.4274/Vhd.77486
Hepatitis C Prevalence and Responses to Pegylated Interferon + Ribavirin Treatment Among Prisoners
  • Hasan Selçuk ÖZGER
  • Ömer KARAŞAHİN
  • Mehmet Armağan TOY
  • Sibel İBA YILMAZ
  • Kenan HIZEL
Viral Hepat J 2017; 23: 71-75 DOI: 10.4274/vhd.0007
Comparison of the Efficacy of Standard Interferon Alpha 2a Plus Ribavirin and PegylatedInterferon Alpha 2a Plus Ribavirin Combination Therapies in the Treatment of ChronicHepatitis C Infection
  • Şua SÜMER
  • Onur URAL
  • Nazlım AKTUĞDEMİR
  • Gaye URAL
  • Mehmet BALCI
  • Nebahat DİKİCİ
Viral Hepat J 2009; 14: 89-90
Waiting for Interferon-free Regimens for Chronic Hepatitis C Patients: A Multicenter Observational Study
  • Rahmet Güner
  • Zeliha Koçak Tufan
  • Cemal Bulut
  • Gülden Ersöz
  • Ayşe Batırel
  • Bahar Kaçmaz
  • Bircan Kayaaslan
  • Nurcan Baykam
  • Alpay Arı
  • Aziz Öğütlü
  • Saygın Nayman Alpat
  • Yasemin Durdu
  • Özgür Günal
  • Yunus Gürbüz
  • Emsal Aydın
  • Selma Tosun
  • Fehmi Tabak
  • Association to Combat Viral Hepatitis-Academic Camp Group
Viral Hepat J 2014; 20: 95-100 DOI: 10.4274/vhd.98698
Combination of Interferon Induction Therapy and Ribavirin in Chronic Hepatitis C Patients: Results of a Multicenter Clinical Trial
  • Bilgehan AYGEN
  • Orhan YILDIZ
  • Rahmet ÇAYLAN
  • Iftihar KÖKSAL
  • Nese SALTOGLU
  • Yesim TASOVA
  • Hakan LEBLEBICIOGLU
  • Saban ESEN
Viral Hepat J 2004; 9: 123-129

Research Article

The Long-term (10.6 years) Outcome of Hepatitis C patients with Sustained Virologic Response Following Treatment with Pegylated Interferon + Ribavirin
  • Osman Özdoğan
  • Serkan Yaraş
Viral Hepat J 2020; 26: 22-27 DOI: 10.4274/vhd.galenos.2019.2019.0042
Assessment of Quality of Life of Patients with Chronic Hepatitis B and C Treated with Pegylated Interferon-alpha
  • Handan ALAY
  • Kemalettin ÖZDEN
  • Serpil EROL
  • Neslihan ÇELİK
  • Emine PARLAK
  • Mehmet PARLAK
Viral Hepat J 2018; 24: 25-42 DOI: 10.4274/vhd.2017.0016
Does Pegylated-Interferon Still Have High Efficacy Treatment Properties Against Chronic Hepatitis B?
  • Figen SARIGÜL YILDIRIM
  • Ülkü USER
  • Murat SAYAN
  • Nefise ÖZTOPRAK
Viral Hepat J 2018; 24: 90-95 DOI: 10.4274/vhd.2018.0006
The Effect of the Administration of Interferon and Steroids on Regulatory T-cells in the Liver, Spleen, and Bone Marrow of Mice
  • Esra Zerdali
  • Esra Özpınar
  • Ecem Akdoğan
  • Bilgül Mete
  • Neşe Saltoğlu
  • Fehmi Tabak
  • Reşat Özaras
Viral Hepat J 2022; 28: 110-116 DOI: 10.4274/vhd.galenos.2023.2023-4-3
Examination of Mutations in the HBsAg and Polymerase Genes Induced by Pegylated Interferon Alpha and Oral Antivirals Used in the Treatment of Chronic Hepatitis B
  • Elif Sargın Altunok
  • Sila Akhan
  • Murat Sayan
Viral Hepat J 2020; 26: 141-150 DOI: 10.4274/vhd.galenos.2020.2020.0017

Case Report

Development of Acute Pancreatitis Due to Pegylated Interferon Alpha 2a in a Patient with Chronic Hepatitis B: A Case Report
  • Şükran KÖSE
  • Melda TÜRKEN
  • Mehmet TANRISEV
  • Gülgün AKKOÇLU
Viral Hepat J 2015; 21: 35-37 DOI: 10.4274/vhd.69875
Psoriasis after Pegylated Interferon-Treatment of Chronic Hepatitis B Infection: Case Report
  • Sezin AŞIK AKMAN
  • Şükran KÖSE
  • Oya HALICIOĞLU
  • Ümit BAYOL
  • Sibel ALPER
Viral Hepat J 2009; 14: 77-80
Pegylated Interferon Alpha-2b Associated Cutaneous Necrosis: A Case Report
  • Rahmet GÜNER
  • Derya YAPAR
  • Murat SARICI
  • Mehmet Akin TAŞYARAN
Viral Hepat J 2010; 16: 77-79
Dermatological Side Effects in a Patient with Hepatitis C Infection During Treatment with Pegylated Interferon/Ribavirin+Telaprevir: A Case Report
  • Tugba SARI
  • Suda Tekin KORUK
  • Fatih TEMOÇIN
Viral Hepat J 2014; 20: 81-84 DOI: 10.4274/vhd.38358
Pegylated Interferon Alpha 2a Associated Dermatitis: A Case Report
  • Saygın NAYMAN ALPAT
  • Salih Atakan NEMLİ
  • Nurettin ERBEN
  • Elif DOYUK KARTAL
  • İlhan ÖZGÜNEŞ
  • Gaye USLUER
Viral Hepat J 2009; 14: 116-118
Sensorineural Hearing Loss Due to Pegylated Interferon Alfa/Ribavirin Therapy: A Case Report
  • Tuğba SARI
  • Süda TEKİN KORUK
  • Alaaddin ZİREK
Viral Hepat J 2012; 18: 123-125 DOI: 10.4274/Vhd.66376

Letter to the Editor

Paradoxes in Novel Hepatitis C Therapies: Is Combination of Sofosbuvir and Ribavirin Without Interferon Effective in Genotype 1b Chronic HCV Patients?
  • Ergenekon KARAGÖZ
  • Vedat TURHAN
  • Asim ÜLÇAY
  • Alpaslan TANOĞLU
  • Hakan ERDEM
Viral Hepat J 2015; 21: 62-64 DOI: 10.4274/vhd.33042

Other

Induction Therapy with Interferon-Alpha 2b in Naive Chronic Hepatitis C Patients
  • Hakan LEBLEBICIOGLU
  • Mustafa SÜNBÜL
  • Bilgehan AYGEN
  • Yasemin ERSOY
  • Kemalettin AYDIN
  • Ilyas DÖKMETAS
Viral Hepat J 2003; 8: 0-0
KRONIK VIRAL HEPATIT TEDAVISINDE INTERFERONUN HEMATOLOJIK PARAMETRELERE ETKISI
  • Dinç DINÇER
  • Kadri DEMIR
  • Sabahattin KAYMAKOGLU
  • Yilmaz ÇAKALOGLU
  • Fatih BESISIK
  • Ziyaettin DURAKOGLU
  • Salih TÜRKOGLU
  • Selim BADUR
  • Atilla ÖKTEN
Viral Hepat J 2000; 6: 0-0
CHRONIC HEPATIT C TREATMENT WITH INTERFERON ALPHA 2b-RIBAVIRIN COMBINATION THERAPY
  • Ismail BALIK
  • Osman MEMIKOGLU
Viral Hepat J 2001; 7: 0-0
COMPARISION OF ALPHA-INTERFERON MONOTHERAPY AND ALPHA-INTERFERON PLUS LAMIVUDINE COMBINATION FOR EFFICACY AND SAFETY IN CHRONIC HEPATITIS B
  • Güven ÇELEBI
  • Yunus GÜRBÜZ
  • Rüçhan TÜRKYILMAZ
Viral Hepat J 2001; 7: 0-0
Case Report: Seconder Lung Tuberculosis Which Aggrevated During IFN-a Therapy
  • Irfan SENCAN
  • Mustafa YILDIRIM
  • Peri Meram ARBAK
Viral Hepat J 2003; 8: 0-0
Treatment of Chronic Hepatitis C with Alpha Interferon in Hemodialysis Patients
  • Fatih BESISIK
  • Salih TÜRKOGLU
  • Sabahattin KAYMAKOGLU
  • Mürvet BOGAZCI
  • Levent ERDEM
  • Mehmet SEVER
  • Alaattin YILDIZ
  • Selim GÜREL
  • Yilmaz ÇAKALOGLU
  • Atilla ÖKTEN
  • Selim BADUR
Viral Hepat J 1995; 1: 57-60
Evaluation of the Effectiveness of Interferon-Alpha and Lamivudine Combination Therapy inPatients with Chronic Hepatitis B Infection
  • Tansu YAMAZHAN
  • Bilgin ARDA
  • Ekin ERTEM
  • Sercan ULUSOY
  • Demir SERTER
Viral Hepat J 2004; 9: 61-66
Evaluation of Thyroid Functions During Interferon-Alpha Treatment ofPatients with Chronic Viral Hepatitis
  • Mustafa SÜNBÜL
  • Ertan SAHBAT
  • Mehmet AKKUS
  • Saban ESEN
  • Hakki KAHRAMAN
  • Hakan LEBLEBICIOGLU
Viral Hepat J 2004; 9: 67-71
Interferon Alpha 2b Therapy in Acute Viral Hepatitis C:Two Years Followed Up of Seven Case
  • Funda SIMSEK
  • Fatma YÜKSEL
  • Lütfü SAVAS
Viral Hepat J 2004; 9: 72-75
Alfa-Interferon Treatment in Children with Chronic Hepatitis B Virus Infection
  • Sema AYDOGDU
  • Erhun KASIRGA
  • Ayse Mukadder SELIMOGLU
  • Kaan KAVAKLI
  • Tijen ÖZACAR
  • Aysin ZEYTINOGLU
  • Gül YÜCE
  • Funda YILMAZ
  • Rasit Vural YAGCI
Viral Hepat J 1997; 3: 83-86
Hepatitis G Virus Infection and Chronic Liver Disease: Prevalence and The Effect on Clinical Findings and Interferon Therapy
  • Atilla ÖKTEN
  • Kadri DEMIR
  • Mürvet BOZACI
  • Sabahattin KAYMAKOGLU
  • Salih TÜRKOGLU
  • Selim BADUR
  • Yilmaz ÇAKALOGLU
Viral Hepat J 1997; 3: 90-93
Interferon Therapy in the Chronic Hepatitis Due to Hepatitis B Virus
  • Nafiz KOÇAK
  • Sedat ÖZKÜÇÜK
  • Hüsnü ALTUNAY
  • M. Fevzi ÖZSOY
  • Alaattin PAHSA
  • Selim BADUR
  • O. Sadi YENEN
Viral Hepat J 1999; 5: 91-95
Interferon Therapy in Chronic Hepatitis B Infection
  • Yesim TASOVA
  • Nese SALTOGLU
  • Özlem ERDURAK
  • Hasan S.Z. AKSU
Viral Hepat J 1996; 2: 96-102
A Case of Erythema Multiforme Related to Pegylated Interferon-a2a Plus Ribavirin Treatment for Chronic Hepatitis C Virus Infection
  • Ilhan ÖZGÜNES
  • Elif DOYUK KARTAL
  • Nurettin ERBEN
  • Saygin NAYMAN ALPAT
  • Gaye USLUER
Viral Hepat J 2006; 11: 101-104
Recombinant Hepatitis B Vaccine and Recombinant Interferon + ? Combination Therapy in Chronic B Hepatitis
  • Selim GÜREL
  • Enver DOLAR
  • Macit GÜLTEN
  • S. Giray NAK
  • Yusuf KARAASLAN
Viral Hepat J 1999; 5: 114-116
The Results of Interferon - ? and Lamivudine Combinotion Therapy in Non-Responder or Relapser Chronic Hepatitis B
  • Selim GÜREL
  • Enver DOLAR
  • Macit GÜLTEN
  • S. Giray NAK
  • Yusuf KARAASLAN
Viral Hepat J 1999; 5: 117-119
THE EVALUATION OF INTRAERYTHROCYTE SUPEROXIDE DISMUTASE AND CATALASE ACTIVITY IN THE PATIENTS WITH HEPATITIS C INFECTION
  • Aysun BAY KARABULUT
  • Yasar BAYINDIR
  • Çetin ÖZTÜRK
  • Emine SÖNMEZ
  • Kadir BATICIOGLU
  • Engin GÖZÜKARA
Viral Hepat J 2002; 8: 447-450
INTERFERON TREATMENT AND ITS RESULTS IN CHRONIC HEPATITIS 8
  • Fatma SIRMATEL
  • Mehmet CANDAN
  • GönüI BAKIR
  • Öcal SIRMATEL
  • Kemal BAKIR
Viral Hepat J 2002; 8: 525-528